FDA accepts Milestone's response on Cardamyst nasal spray, sets new PDUFA date; company raises $52.5 million to support ...

The US Food and Drug Administration approved a new nasal spray as a rapid treatment for migraine pain in adults. The nasal spray zavegepant, sold as Zavzpret, may relieve pain and other bothersome ...

The Food and Drug Administration has declined to approve an alternative to epinephrine autoinjectors such as EpiPens, telling the maker of a nasal spray that more study is required. ARS Pharma ...

FDA approves new nasal spray to treat potentially life-threatening allergic reactions 01:58. The Food and Drug Administration approved a nasal spray intended to treat severe allergic reactions on ...

The Food and Drug Administration has approved a nasal spray aimed at fast treatment for migraines, pharmaceutical company Pfizer said Friday. Zavegepant, sold under the brand name Zavzpret, was ...

The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen.

The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...

The Food and Drug Administration endorsed Opvee, a nasal spray update of the drug nalmefene, which was first approved as an injection in the mid-1990s but later removed from the market due to low ...

The U.S. Food and Drug Administration has expanded its approval of Spravato, an antidepressant nasal spray. The drug is now cleared for use as a standalone treatment for depression.

In January 2020, readers asked us about the accuracy of a story that claimed the U.S. Food and Drug Administration (FDA) had approved a new cocaine nasal spray for use as a local anesthetic.

The nasal spray "Neffy" is the first needle-free option for severe allergic reactions that the FDA has approved. The spray would be an alternative to EpiPens.